A relative newcomer to the global biopharmaceutical market is seeking to transform the industry through open innovation. Transparency Life Sciences, founded in 2010, claims to be the first drug company based on open principles of collaboration and design. The company’s strategy involves reaching out directly to scientists and clinicians as well as patients and their families.
